Platelet Aggregation Inhibitors: Clinical Trials

2 trials for Platelet Aggregation Inhibitors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)
Cangrelor - Platelet Aggregation Inhibitors
Phase 2UnknownOspedale Santa Croce-Carle Cuneo1402019-06-012019-03-05
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
Vicagrel 5mg, Vicagrel 6mg, Vicagrel 7.5mg - Coronary Artery Disease, Percutaneous Coronary Intervention
Phase 2CompletedJiangsu vcare pharmaceutical technology co., LTD2792018-08-302019-09-23

Narrower conditions

Coronary Artery Disease (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Vascular Diseases (1)

Interventions

Clopidogrel (1)  ·  cangrelor (1)  ·  methyl 2-(2-acetoxy-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate (1)

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD (1)  ·  Ospedale Santa Croce-Carle Cuneo (1)

Countries

China (1)